New virtual screening strategy identifies existing drug that inhibits Covid-19 virus

Traditional Ghanaian medicines show promise against tropical diseases
1 January 2021
Nanoparticle drug-delivery system developed to treat brain disorders
1 January 2021

New virtual screening strategy identifies existing drug that inhibits Covid-19 virus

A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat Covid-19. Haiping Zhang of the Shenzhen Institutes of Advanced Technology in Shenzhen, China, and colleagues present these findings in the open-access journal PLOS Computational Biology.

Comments are closed.